Búsqueda | BVS Medicinas Tradicionales, Complementarias, e Integrativas en las Américas

1.

Epirubicin-vinorelbine vs FEC100 for node-positive, early breast cancer: French Adjuvant Study Group 09 trial.

Kerbrat, P; Roché, H; Bonneterre, J; Veyret, C; Lortholary, A; Monnier, A; Fumoleau, P; Fargeot, P; Namer, M; Chollet, P; Goudier, M-J; Audhuy, B; Simon, H; Montcuquet, P; Eymard, J-C; Walter, S; Clavère, P; Guastalla, J-P.

Br J Cancer ; 96(11): 1633-8, 2007 Jun 04.

Artículo en Inglés | MEDLINE | ID: mdl-17505516

2.

Long-term cardiac toxicity after adjuvant epirubicin-based chemotherapy in early breast cancer: French Adjuvant Study Group results.

Fumoleau, P; Roché, H; Kerbrat, P; Bonneterre, J; Romestaing, P; Fargeot, P; Namer, M; Monnier, A; Montcuquet, P; Goudier, M-J; Luporsi, E.

Ann Oncol ; 17(1): 85-92, 2006 Jan.

Artículo en Inglés | MEDLINE | ID: mdl-16251204

3.

Improved disease-free survival with epirubicin-based chemoendocrine adjuvant therapy compared with tamoxifen alone in one to three node-positive, estrogen-receptor-positive, postmenopausal breast cancer patients: results of French Adjuvant Study Group 02 and 07 trials.

Namer, M; Fargeot, P; Roché, H; Campone, M; Kerbrat, P; Romestaing, P; Monnier, A; Luporsi, E; Montcuquet, P; Bonneterre, J.

Ann Oncol ; 17(1): 65-73, 2006 Jan.

Artículo en Inglés | MEDLINE | ID: mdl-16361531

4.

Secondary leukemia after epirubicin-based adjuvant chemotherapy in operable breast cancer patients: 16 years experience of the French Adjuvant Study Group.

Campone, M; Roché, H; Kerbrat, P; Bonneterre, J; Romestaing, P; Fargeot, P; Namer, M; Monnier, A; Montcuquet, P; Goudier, M-J; Fumoleau, P.

Ann Oncol ; 16(8): 1343-51, 2005 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-15905306

5.

Phase II study of vinorelbine in patients with androgen-independent prostate cancer.

Oudard, S; Caty, A; Humblet, Y; Beauduin, M; Suc, E; Piccart, M; Rolland, F; Fumoleau, P; Bugat, R; Houyau, P; Monnier, A; Sun, X; Montcuquet, P; Breza, J; Novak, J; Gil, T; Chopin, D.

Ann Oncol ; 12(6): 847-52, 2001 Jun.

Artículo en Inglés | MEDLINE | ID: mdl-11484963

BVS Medicinas Tradicionales, Complementarias, e Integrativas en las Américas - MTCI

Configurar filtros

Su selección (0)

Formato de exportación:

Exportar:

Epirubicin-vinorelbine vs FEC100 for node-positive, early breast cancer: French Adjuvant Study Group 09 trial.

Long-term cardiac toxicity after adjuvant epirubicin-based chemotherapy in early breast cancer: French Adjuvant Study Group results.

Improved disease-free survival with epirubicin-based chemoendocrine adjuvant therapy compared with tamoxifen alone in one to three node-positive, estrogen-receptor-positive, postmenopausal breast cancer patients: results of French Adjuvant Study Group 02 and 07 trials.

Secondary leukemia after epirubicin-based adjuvant chemotherapy in operable breast cancer patients: 16 years experience of the French Adjuvant Study Group.

Phase II study of vinorelbine in patients with androgen-independent prostate cancer.